CME accredited module

Are you confident in managing your patients with childhood psoriasis? Are you up-to-date with the latest guidelines and treatments available? Take this interactive eLearning module to learn about the burden of childhood psoriasis for patients and their families and why effective treatment is so important to improve future health.

Course overview

Take this interactive CME module and explore the challenges of paediatric psoriasis with our experts offering their advice on all aspects of this burdensome disease.

Creation of this CME module was funded by an educational grant from Novartis Pharma AG.

System Requirements

Faculty

Professor Amy Paller. Professor of Paediatrics and Dermatology at the Northwestern University Feinberg School of Medicine, Chicago, US. Professor Paller is author of almost 500 peer-reviewed publications and has also edited several major textbooks in dermatology. Her laboratory focuses on skin innervation in inflammatory diseases and topically delivered gene regulation through nanotherapy, including for psoriasis.

Professor Tiago Torres. Professor of Dermatology at the Abel Salazar Institute of Biomedical Sciences, University of Porto, Portugal. Currently, Dr Torres is the Head of the Immunodermatology Unit (psoriasis, atopic dermatitis and auto-immune diseases) and Clinical Trials Unit of the Department of Dermatology of Centro Hospitalar Universitário do Porto. Through the years he has been principal investigator for several psoriasis and atopic dermatitis clinical trials.

Professor Efstratios Vakirlis. Assistant Professor of Dermatology at the Aristotle University School of Medicine, Thessaloniki, Greece. Dr Vakirlis supports medical professional education and regularly instructs residents and medical students in dermatology and immunology. Additionally, he has published scientific articles in several high-impact peer-reviewed journals. He is an investigator in numerous clinical trials and a member of several professional and research organisations.

Further information

Quick baseline questions will be asked at the start of each section to assess your background and understanding. You will not be assessed on your responses to these questions.

Evaluation questions will be asked at the end of each section. You must achieve a score of 70% or above to pass the course and be able to print your certificate.

On completion of this course, participants will understand that:

• Psoriasis occurs in children of all ages and comorbidities are often present
• Diagnosis and measurement of quality of life is more difficult in children
• Treatment options for children with moderate-to-severe psoriasis are more limited than those for adults but are improving
• Clinical trials are ongoing for more targeted biologic therapies
• Having well-controlled psoriasis in paediatric patients will reduce the impact of psoriasis in later life